Finance

Lists
314130:KOSDAQ
Genome&Company Inc
â‚©3,435.00
+2.54%
(+85.00) 1D
Sep 4, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 314130...
Open
â‚©3,400
High
â‚©3,500
Low
â‚©3,350
Mkt. cap
179.65B
Avg. vol.
425.35K
Volume
117.84K
52-wk high
â‚©10,180
52-wk low
â‚©2,470
EPS
-â‚©965
Shares outstanding
52.30M
No. of employees
97
Open
â‚©3,400
High
â‚©3,500
Low
â‚©3,350
Mkt. cap
179.65B
Avg. vol.
425.35K
Volume
117.84K
52-wk high
â‚©10,180
52-wk low
â‚©2,470
EPS
-â‚©965
Shares outstanding
52.30M
No. of employees
97
About Genome&Company Inc
CEOHong Yoo Seok
Employees97
Founded2015
Headquarters-
SectorBiotechnology
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
5.81B
6.56B
5.87B
5.78B
Cost of goods sold
2.65B
3.31B
2.72B
2.47B
Cost of revenue
2.65B
3.31B
2.72B
2.47B
Research and development expenses
2.87B
3.16B
2.82B
2.06B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.53B
7.02B
7.05B
6.38B
Operating expense
10.56B
11.34B
10.18B
9.41B
Total operating expenses
13.22B
14.65B
12.90B
11.88B
Operating income
-7.41B
-8.09B
-7.03B
-6.10B
Other non operating income
3.39B
1.83M
28.17B
5.15M
EBT including unusual items
-7.22B
-8.33B
13.94B
-7.16B
EBT excluding unusual items
-5.05B
-8.29B
20.04B
-6.44B
Income tax expense
-379.41M
-281.46M
-374.97M
-353.80M
Effective tax rate
5.26%
3.38%
-2.69%
4.94%
Other operating expenses
-
-
-
-
Net income
-6.44B
-7.53B
14.61B
-6.35B
Net profit margin
-110.91%
-114.78%
248.95%
-109.79%
Earnings per share
-
-
-
-
Interest and investment income
526.62M
248.05M
208.89M
240.58M
Interest expense
-1.29B
-990.75M
-1.29B
-732.27M
Net interest expenses
-762.79M
-742.69M
-1.08B
-491.70M
Depreciation and amortization charges
443.81M
435.21M
313.31M
426.74M
EBITDA
-5.51B
-6.23B
-6.05B
-4.49B
Gain or loss from assets sale
-
35.07M
41.82M
20.01M
AI content may include mistakes. Learn more
Google apps